These SNPs are found to further enhance the promoter activity of MYLKP1 compared to the wild type, indicating that MYLKP1 functions as a colon cancer‐promoting pseudogene, with its genetic variants exacerbating colon cancer risk specifically in African American populations [23]. This evidence concerns the gene MYLKP1 and malignant colon neoplasm.